Cargando…

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years

BACKGROUND: Soft tissue sarcomas are rare entities with over 50 histological subtypes. Liposarcoma (LS) is the most common neoplasm in this group; it is a complex neoplasm that is divided into different histological subtypes. Different therapy options, such as surgical resection, radiation, and chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Knebel, Carolin, Lenze, Ulrich, Pohlig, Florian, Lenze, Florian, Harrasser, Norbert, Suren, Christian, Breitenbach, Jonathan, Rechl, Hans, von Eisenhart-Rothe, Rüdiger, Mühlhofer, Heinrich M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469180/
https://www.ncbi.nlm.nih.gov/pubmed/28606068
http://dx.doi.org/10.1186/s12885-017-3398-y
_version_ 1783243541463433216
author Knebel, Carolin
Lenze, Ulrich
Pohlig, Florian
Lenze, Florian
Harrasser, Norbert
Suren, Christian
Breitenbach, Jonathan
Rechl, Hans
von Eisenhart-Rothe, Rüdiger
Mühlhofer, Heinrich M. L.
author_facet Knebel, Carolin
Lenze, Ulrich
Pohlig, Florian
Lenze, Florian
Harrasser, Norbert
Suren, Christian
Breitenbach, Jonathan
Rechl, Hans
von Eisenhart-Rothe, Rüdiger
Mühlhofer, Heinrich M. L.
author_sort Knebel, Carolin
collection PubMed
description BACKGROUND: Soft tissue sarcomas are rare entities with over 50 histological subtypes. Liposarcoma (LS) is the most common neoplasm in this group; it is a complex neoplasm that is divided into different histological subtypes. Different therapy options, such as surgical resection, radiation, and chemotherapy, are available. Depending on the subtype, location, status of the resection margins and metastatic status, different therapy options are used. Therefore, the aim of this study was to determine the prognostic factors influencing the survival of patients affected by LS with consideration for the grading, histological subtype, state of the resection margin, size, location, metastases and local recurrence in a retrospective, single-centre analysis over 15 years. METHODS: We included 133 patients (male/female = 67/66) in this study. We recorded the histologic subtype, grade, TNM classification, localization, biopsy technique, tumour margins, number of operations, complications, radiation and dose, chemotherapy, survival, recrudescence, metastases and follow-up. Survivorship analysis was performed. RESULTS: We detected 56 (43%; 95%-CI 34.6–51.6%) atypical LS cases, 21 (16.2%; 95%-CI 9.8–22.5) dedifferentiated LS cases, 40 (30.8%; 95%-CI 22.8–38.7) myxoid LS cases and 12 (9.2%; 95%-CI 4.3–14.2) pleomorphic LS cases. G1 was the most common grade, which was followed by G3. Negative margins (R0) were detected in 67 cases (53.6%; 95%-CI 44.9–62.3) after surgical resection. Local recurrence was detected in 23.6% of cases. The presence of metastases and dedifferentiated LS subtype as well as negative margins, grade and tumour size are significant prognostic factors of the survival rates (p < 0.015). CONCLUSION: Grading, LS subtype, negative margins after surgery, metastases and tumour size are independently associated with disease-specific survival, and patients with local recurrence had lower survival rates. We hope our investigation may facilitate a further prospective study and clinical decision-making in LS.
format Online
Article
Text
id pubmed-5469180
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54691802017-06-14 Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years Knebel, Carolin Lenze, Ulrich Pohlig, Florian Lenze, Florian Harrasser, Norbert Suren, Christian Breitenbach, Jonathan Rechl, Hans von Eisenhart-Rothe, Rüdiger Mühlhofer, Heinrich M. L. BMC Cancer Research Article BACKGROUND: Soft tissue sarcomas are rare entities with over 50 histological subtypes. Liposarcoma (LS) is the most common neoplasm in this group; it is a complex neoplasm that is divided into different histological subtypes. Different therapy options, such as surgical resection, radiation, and chemotherapy, are available. Depending on the subtype, location, status of the resection margins and metastatic status, different therapy options are used. Therefore, the aim of this study was to determine the prognostic factors influencing the survival of patients affected by LS with consideration for the grading, histological subtype, state of the resection margin, size, location, metastases and local recurrence in a retrospective, single-centre analysis over 15 years. METHODS: We included 133 patients (male/female = 67/66) in this study. We recorded the histologic subtype, grade, TNM classification, localization, biopsy technique, tumour margins, number of operations, complications, radiation and dose, chemotherapy, survival, recrudescence, metastases and follow-up. Survivorship analysis was performed. RESULTS: We detected 56 (43%; 95%-CI 34.6–51.6%) atypical LS cases, 21 (16.2%; 95%-CI 9.8–22.5) dedifferentiated LS cases, 40 (30.8%; 95%-CI 22.8–38.7) myxoid LS cases and 12 (9.2%; 95%-CI 4.3–14.2) pleomorphic LS cases. G1 was the most common grade, which was followed by G3. Negative margins (R0) were detected in 67 cases (53.6%; 95%-CI 44.9–62.3) after surgical resection. Local recurrence was detected in 23.6% of cases. The presence of metastases and dedifferentiated LS subtype as well as negative margins, grade and tumour size are significant prognostic factors of the survival rates (p < 0.015). CONCLUSION: Grading, LS subtype, negative margins after surgery, metastases and tumour size are independently associated with disease-specific survival, and patients with local recurrence had lower survival rates. We hope our investigation may facilitate a further prospective study and clinical decision-making in LS. BioMed Central 2017-06-12 /pmc/articles/PMC5469180/ /pubmed/28606068 http://dx.doi.org/10.1186/s12885-017-3398-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Knebel, Carolin
Lenze, Ulrich
Pohlig, Florian
Lenze, Florian
Harrasser, Norbert
Suren, Christian
Breitenbach, Jonathan
Rechl, Hans
von Eisenhart-Rothe, Rüdiger
Mühlhofer, Heinrich M. L.
Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title_full Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title_fullStr Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title_full_unstemmed Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title_short Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
title_sort prognostic factors and outcome of liposarcoma patients: a retrospective evaluation over 15 years
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469180/
https://www.ncbi.nlm.nih.gov/pubmed/28606068
http://dx.doi.org/10.1186/s12885-017-3398-y
work_keys_str_mv AT knebelcarolin prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT lenzeulrich prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT pohligflorian prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT lenzeflorian prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT harrassernorbert prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT surenchristian prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT breitenbachjonathan prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT rechlhans prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT voneisenhartrotherudiger prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years
AT muhlhoferheinrichml prognosticfactorsandoutcomeofliposarcomapatientsaretrospectiveevaluationover15years